Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $96
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson maintains a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and raises the price target from $90 to $96.
June 09, 2023 | 9:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a Buy rating on Merit Medical Systems and raises the price target from $90 to $96.
The news directly mentions Merit Medical Systems (MMSI) and the raised price target from $90 to $96 by Needham analyst Mike Matson. This positive analyst rating and increased price target indicate a bullish outlook for the stock, which is likely to have a positive short-term impact on MMSI's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100